Alan L. Crane, MBA
Vice Chairman, Board of Directors
Mr. Crane is currently President and CEO of Tempo Pharmaceuticals, Inc. He has also been a venture partner at Polaris Ventures since April of 2002. From 2002 until 2006, Mr. Crane was President and CEO of Momenta Pharmaceuticals. He joined Momenta as the fifth employee and built the company into a public company, creating an advanced and diversified pipeline, entering into two strategic collaborations with the Sandoz division of Novartis, and raising $275M. Prior to this, Mr. Crane was senior vice president of global corporate development at Millennium Pharmaceuticals, where he was responsible for leading Millennium's strategic partnering, mergers and acquisitions, and licensing activities, generating over $2B in partner funding and acquiring 19 development stage products. Prior to Millennium, Mr. Crane was a marketing executive at Dupont-Merck and a consultant with the Boston Consulting Group and Arthur D. Little.
He serves on the boards of Momenta Pharmaceuticals, Sirtris Pharmaceuticals, Adnexus and Vaccinex, and is a member of the board of Children's Hospital Trust and a founder and member of the board of the Autism Consortium.
He received his M.B.A. in 1992 and his B.A. summa cum laude and M.A. in 1986, all from